Huawen Li Selected Research

Huawen Li Research Topics

Disease

6	Neoplasms (Cancer) 03/2023 - 10/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2023 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2012 - 08/2011
3	Leukemia 11/2011 - 07/2010
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 10/2011 - 08/2011
1	Obesity 04/2024
1	Pelvic Organ Prolapse 10/2023
1	Endometrial Neoplasms (Endometrial Cancer) 03/2023
1	Atherosclerosis 02/2023
1	Insulin Resistance 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Adenocarcinoma 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Arsenic Poisoning 01/2020
1	Hyperglycemia 01/2019
1	Inflammation (Inflammations) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Hypoxia (Hypoxemia) 08/2012
1	Lymphatic Metastasis 10/2011
1	Hematologic Diseases (Blood Diseases) 07/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2009
1	Carcinoma (Carcinomatosis) 05/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
3	AntioxidantsIBA 04/2024 - 01/2019
2	ORALIT (ORS)IBA 01/2022 - 01/2022
2	3,4-dihydroxyphenylpyruvic acidIBA 01/2022 - 01/2022
2	3-(3,5-dihydroxyphenyl)-1-propanoic acidIBA 01/2022 - 01/2022
2	LuciferasesIBA 12/2018 - 10/2011
2	p38 Mitogen-Activated Protein KinasesIBA 08/2012 - 08/2011
2	Sodium-Hydrogen Exchanger 1IBA 01/2012 - 09/2011
1	coenzyme Q10 (CoQ10)IBA 04/2024
1	GlycolipidsIBA 04/2024
1	polycaprolactoneIBA 10/2023
1	Fibroins (Fibroin)IBA 10/2023
1	napabucasinIBA 03/2023
1	astaxanthine (astaxanthin)IBA 02/2023
1	Insulin (Novolin)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Coatomer Protein (Archain)IBA 01/2022
1	ParaffinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Drinking WaterIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	Dimethyl FumarateIBA 01/2019
1	InterleukinsIBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Heme Oxygenase-1IBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 12/2018
1	RE1-silencing transcription factorIBA 12/2018
1	Superoxides (Superoxide)IBA 09/2017
1	Metformin (Glucophage)FDA LinkGeneric 02/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2012
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 12/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 08/2012
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Interleukin-8 (Interleukin 8)IBA 08/2012
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2012
1	cariporideIBA 11/2011
1	Sodium-Hydrogen ExchangersIBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2011
1	Lipocalin-2IBA 10/2011
1	Imatinib Mesylate (Gleevec)FDA Link 09/2011
1	MidkineIBA 07/2010
1	Rhodamine 123IBA 07/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009
1	Superoxide DismutaseIBA 05/2009
1	Peroxynitrous Acid (Peroxynitrite)IBA 05/2004

Therapy/Procedure

1	Subcutaneous Injections 11/2011
1	Therapeutics 10/2011